For basic research advancing beyond the academic realm into product development, the NIH provides non-dilutive federal funding through the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. The NIH SBIR/STTR programs award over $1.25 billion in R&D funding annually to qualified small businesses developing game-changing technologies. For those familiar with NIH …
Join the Northern Virginia BioHub for their February Biotech & Beer. Special guest, Dr. Jessica Dymond, Vice President of Technology at In-Q-Tel, whose mission is to invest in cutting-edge technologies to enhance the national security of the United States, will be discussing her career in synthetic biology and biosecurity, as well as highlighting her current …
Join RBTC for an exciting evening of networking and innovation at Beer & Biotech, an ecosystem-building series that bridges the worlds of biotechnology and entrepreneurship. This year-long series is set to bring together a diverse array of professionals, including investors, physicians, academics, inventors, startups, and influential state and regional leaders in the biotech industry.
Join the AFCEA for the TechNet Emergence Conference, set to take place March 11-12, 2024, at the Hyatt Regency in Reston, Virginia. The Armed Forces Communications & Electronics Association International (AFCEA) knows the pace of technology is ever-increasing, moving too fast for most people to keep up with one sector, let alone multiple areas of interest. …
Register today and join your friends from Virginia Bio in June, at the BIO International Convention, at the San Diego Convention Center. The BIO International Convention is the largest and most consequential gathering of the biotech community in the world. It’s where business and breakthroughs converge on a global level. We hope to see you …
Register to attend the first NIH technology webinar of the year on January 31, featuring a potential novel treatment for Retinitis Pigmentosa (RP). Attendees will learn about a potential, novel treatment for Retinitis Pigmentosa (RP). Over 100,000 people in the U.S. and 1.5 million people worldwide suffer from RP, which leads to progressive photoreceptor cell …